5th Circ. Revives Unfair Competition Fight Over Arthritis Drug
By Dorothy Atkins · April 11, 2025, 5:28 PM EDT
The Fifth Circuit has revived Zyla Life Sciences LLC's lawsuit seeking to block Texas rival Wells Pharma from selling rheumatoid arthritis drug suppositories that aren't U.S. Food and Drug Administration-approved, rejecting...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login